Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pipettes Offer Quality Assurance for Endotoxin-Sensitive Applications

By LabMedica International staff writers
Posted on 11 May 2010
A range of serological pipettes is now certified nonpyrogenic to 0.01 ELISA Units (EU)/mL, significantly lower than the market standard of 0.25 EU/mL. More...
The range has also been validated nonhemolytic.

When medical device and pharmaceutical manufacturers perform tests to ensure that their products are free from endotoxins, it is extremely important for them to have confidence in the equipment and materials that they use.

Similarly, when pipetting blood and blood products, it is important that the polymer used does not have a detrimental effect on the sample. Validated nonhemolytic, the serological pipettes protect samples and provide valuable assurance that they will not interfere with the results of hemolysis tests.

Certified nonpyrogenic to a very low level, Sterilin (Bargoed, UK) serological pipettes greatly reduce the risk of endotoxin interference in routine laboratory analyses (such as limulus amebocyte lysate--LAL testing) and, therefore, help to ensure the integrity of results.

Sterilin serological pipettes are manufactured from crystal grade polystyrene to ensure excellent clarity. With crisp black print, ascending and descending graduations, and negative graduations for extra capacity, volumes are extremely easy to read, and accurate to ± 1%.

The comprehensive range includes standard pipette sizes (1 mL, 2 mL, 5 mL, 10 mL, 25 mL, and 50 mL) in addition to "Shortie” pipettes (5 mL and 10 mL), which are ideal for use in laminar flow cabinets. The gamma-irradiated pipettes are individually wrapped in paper peel or plastic film to maintain quality during storage.

Related Links:

Sterilin




New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Serological Pipet Controller
PIPETBOY GENIUS
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.